WW's New GLP-1 Drug Platform Boosts Stock

WW's New GLP-1 Drug Platform Boosts Stock

Update: 2025-12-19
Share

Description

Weight Watchers, now WW International, unveils new platform combining GLP-one drugs, personalized plans, and AI-powered body scanner. Post-restructuring, company reduces debt by 70%, raises financial guidance, and sees stock surge. Analysts weigh in on WWs potential as a game-changer in weight management.

The Daily News Now! — Every city. Every story. AI-powered.


Hosted on Acast. See acast.com/privacy for more information.

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

WW's New GLP-1 Drug Platform Boosts Stock

WW's New GLP-1 Drug Platform Boosts Stock